Tazarotenedosage

Trilitas™ gel is for topical use only. Trilitas™ gel is not for ophthalmic, oral, or intravaginal use. Avoid accidental transfer of Trilitas™ gel into eyes, mouth, or other mucous membranes. If contact with mucous membranes occurs, rinse thoroughly with water. Wash hands thoroughly after application. Apply a thin layer of Trilitas™ gel only to the affected area once daily in the evening. Not for ophthalmic, oral, or intravaginal use. If contact with eyes occurs, rinse thoroughly with water.

2.1 Psoriasis

It is recommended that treatment starts with tazarotene gel, 0.05%, with strength increased to 0.1% if tolerated and medically indicated. Apply a thin film (2 mg/cm 2 ) of Trilitas™ gel once per day, in the evening, to cover only the psoriatic lesions on no more than 20% of body surface area. If a bath or shower is taken prior to application, the skin should be dry before applying the gel. If emollients are used, they should be applied at least an hour before application of Trilitas™ gel. Because unaffected skin may be more susceptible to irritation, application of tazarotene to these areas should be carefully avoided. Tazarotene gel was investigated for up to 12 months during clinical trials for psoriasis. 2.2 Acne Cleanse the face gently. After the skin is dry, apply a thin layer (2 mg/cm 2 ) of Trilitas™ gel, 0.1% once per day, in the evening, to the skin where acne lesions appear. Use enough to cover the entire affected area. Trilitas™ gel was investigated for up to 12 weeks during clinical trials for acne. Use effective sunscreens and wear protective clothing while using Trilitas™ gel.